Industry: Biomedicine Region: Denmark Transaction Price: USD 1 million Transaction Method: Equity Investment
Project introduction:
A Danish company is committed to restoring brain health, engaged in research, development, manufacture and commercialization of medicines, and has been at the forefront of scientific research for more than 70 years.
Research and development of new and improved treatment methods is the center of its work. The products ha ve been registered in more than 100 countries and used by about 50 million people every year. The listed drugs include the treatment of Alzheimer's disease, Parkinson's disease, epilepsy, Huntington's disease, depression/anxiety, etc.
We are looking for licensing and cooperation opportunities for central system diseases, focusing on orphan/rare diseases, establishing contact with identified patient groups, and being interested in preclinical and clinical opportunities all over the world or regions.
Cooperation mode:
Looking for partners who are interested in this technology to jointly promote cooperation in various forms such as distribution agency and technical cooperation.